Clinical trial
High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation…
NCT00002784 · ETOP IBCSG Partners Foundation, Other · Completed
Key facts
| NCT number | NCT00002784 |
|---|---|
| Title | High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer |
| Official title | Randomized Trial of High-dose Epirubicin and Cyclophosphamide x 3 Supported by Peripheral Blood Progenitor Cells Versus Anthracycline and Cyclophosphamide x 4 Followed by Cyclophosphamide, Methotrexate, and 5-fluorouracil x 3 as Adjuvant Treatment for High Risk Operable Stage ii and Stage Iii Breast… |
| Acronym | 15-95 |
| Lead sponsor | ETOP IBCSG Partners Foundation, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, CMF regimen, cyclophosphamide, doxorubicin hydrochloride, epirubicin hydrochloride, fluorouracil, mesna, methotrexate, tamoxifen citrate, peripheral blood stem cell transplantation and 2 more |
| Enrollment | 344 |
| Start date | Jun 1, 1996 |
| Primary completion | Aug 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Jul 29, 2004 |
| Last update posted | Apr 4, 2013 |
| Countries | Australia, Switzerland |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: